Systemic therapy of metastatic bladder cancer in the molecular era: current status and future promise.

Systemic therapy of metastatic bladder cancer in the molecular era: current status and future promise.

Item
http://www.wikidata.org/entity/Q37763156
The shortest path is not the one you know: application of biological network resources in precision oncology researchS6K1 and 4E-BP1 are independent regulated and control cellular growth in bladder cancerIntegrative modelling of the influence of MAPK network on cancer cell fate decisionThe role of EGFR family inhibitors in muscle invasive bladder cancer: a review of clinical data and molecular evidenceGenetic variations in the transforming growth factor beta pathway as predictors of bladder cancer risk.Cancer/testis antigens and urological malignanciesHigh epidermal growth factor receptor immunohistochemical expression in urothelial carcinoma of the bladder is not associated with EGFR mutations in exons 19 and 21: a study using formalin-fixed, paraffin-embedded archival tissues.Role of the angiogenic components, VEGFA, FGF2, OPN and RHOC, in urothelial cell carcinoma of the urinary bladder.Therapeutic effect of orally administered microencapsulated oxaliplatin for colorectal cancerEstablishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion.Endothelins and their receptors in cancer: identification of therapeutic targets.Evaluation of Protein Levels of the Receptor Tyrosine Kinase ErbB3 in Serum.
P2860

Systemic therapy of metastatic bladder cancer in the molecular era: current status and future promise.

Item
http://www.wikidata.org/entity/Q37763156
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systemic therapy of metastatic ...... ent status and future promise.
@en
Systemic therapy of metastatic ...... ent status and future promise.
@nl
type
label
Systemic therapy of metastatic ...... ent status and future promise.
@en
Systemic therapy of metastatic ...... ent status and future promise.
@nl
prefLabel
Systemic therapy of metastatic ...... ent status and future promise.
@en
Systemic therapy of metastatic ...... ent status and future promise.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Systemic therapy of metastatic ...... ent status and future promise.
@en
P2093
P2860
P304
P31
P356
10.1517/13543784.2010.496450
P407
P433
P478
P577
P698